Methionine Restriction Increases Insulin Sensitivity in Type-2 Diabetes via miRNA Activation

Methionine Restriction (MR) causes a higher level of circulating and hepatic fibroblastic growth factor 21 (FGF21). This leads to metabolic phenotypes, including increased energy expenditure, insulin sensitivity, and extended lifespan. Previous studies on obese mice have concluded that dietary MR in...

Full description

Bibliographic Details
Main Authors: Li Yuanming, Yu Zifu, Li Tuowei, Li Chuanzi
Format: Article
Language:English
Published: EDP Sciences 2023-01-01
Series:SHS Web of Conferences
Online Access:https://www.shs-conferences.org/articles/shsconf/pdf/2023/23/shsconf_seaa2023_03012.pdf
_version_ 1797740167768834048
author Li Yuanming
Yu Zifu
Li Tuowei
Li Chuanzi
author_facet Li Yuanming
Yu Zifu
Li Tuowei
Li Chuanzi
author_sort Li Yuanming
collection DOAJ
description Methionine Restriction (MR) causes a higher level of circulating and hepatic fibroblastic growth factor 21 (FGF21). This leads to metabolic phenotypes, including increased energy expenditure, insulin sensitivity, and extended lifespan. Previous studies on obese mice have concluded that dietary MR in a high-fat regimen prevents hyperglycemia and improves glucose homeostasis, thus preventing type-2 diabetes, a multifactorial metabolic disease characterized by high blood glucose levels and cell insulin resistance. Recent experiments have shown that cells’ response to dietary MR includes changes in methylation of DNA promoters that activate or repress microRNAs (miRNAs), which are small endogenous nucleotide sequences and contain 18-22 base pairs that control gene expression for lipid metabolism. Considering that the disruption of miRNA levels affects insulin resistance, miRNA potentially plays a role in MR to increase insulin sensitivity for type-2 diabetes. In this paper, we investigate the mechanism of MR influencing the expression level of miRNA-15b to promote insulin sensitivity in obese organisms. Using our in-vitro model, we measured the expression of miRNA-15b in adipocytes cultured in MR and control conditions. Additionally, we compared insulin sensitivity and free fatty acid (FFA) metabolite levels between obese mice on control and MR diets. Taken together, we were able to verify the positive effects of MR in reducing hepatic fatty acid production, decreasing blood glucose levels, and increasing insulin sensitivity. However, miRNA-15b downregulates cells’ insulin signaling pathway and insulin sensitivity. Therefore, we proposed potential influences of MR on other miRNAs in reducing lipid cell differentiation and enhancing insulin sensitivity for future investigation.
first_indexed 2024-03-12T14:08:43Z
format Article
id doaj.art-6a7e14c1f4be4f3188741a5a26b3f3f1
institution Directory Open Access Journal
issn 2261-2424
language English
last_indexed 2024-03-12T14:08:43Z
publishDate 2023-01-01
publisher EDP Sciences
record_format Article
series SHS Web of Conferences
spelling doaj.art-6a7e14c1f4be4f3188741a5a26b3f3f12023-08-21T09:05:40ZengEDP SciencesSHS Web of Conferences2261-24242023-01-011740301210.1051/shsconf/202317403012shsconf_seaa2023_03012Methionine Restriction Increases Insulin Sensitivity in Type-2 Diabetes via miRNA ActivationLi Yuanming0Yu Zifu1Li Tuowei2Li Chuanzi3Beijing City International SchoolThe Williston Northampton SchoolPennsylvania State University, State CollegeXi’an middle school of Shaanxi provinceMethionine Restriction (MR) causes a higher level of circulating and hepatic fibroblastic growth factor 21 (FGF21). This leads to metabolic phenotypes, including increased energy expenditure, insulin sensitivity, and extended lifespan. Previous studies on obese mice have concluded that dietary MR in a high-fat regimen prevents hyperglycemia and improves glucose homeostasis, thus preventing type-2 diabetes, a multifactorial metabolic disease characterized by high blood glucose levels and cell insulin resistance. Recent experiments have shown that cells’ response to dietary MR includes changes in methylation of DNA promoters that activate or repress microRNAs (miRNAs), which are small endogenous nucleotide sequences and contain 18-22 base pairs that control gene expression for lipid metabolism. Considering that the disruption of miRNA levels affects insulin resistance, miRNA potentially plays a role in MR to increase insulin sensitivity for type-2 diabetes. In this paper, we investigate the mechanism of MR influencing the expression level of miRNA-15b to promote insulin sensitivity in obese organisms. Using our in-vitro model, we measured the expression of miRNA-15b in adipocytes cultured in MR and control conditions. Additionally, we compared insulin sensitivity and free fatty acid (FFA) metabolite levels between obese mice on control and MR diets. Taken together, we were able to verify the positive effects of MR in reducing hepatic fatty acid production, decreasing blood glucose levels, and increasing insulin sensitivity. However, miRNA-15b downregulates cells’ insulin signaling pathway and insulin sensitivity. Therefore, we proposed potential influences of MR on other miRNAs in reducing lipid cell differentiation and enhancing insulin sensitivity for future investigation.https://www.shs-conferences.org/articles/shsconf/pdf/2023/23/shsconf_seaa2023_03012.pdf
spellingShingle Li Yuanming
Yu Zifu
Li Tuowei
Li Chuanzi
Methionine Restriction Increases Insulin Sensitivity in Type-2 Diabetes via miRNA Activation
SHS Web of Conferences
title Methionine Restriction Increases Insulin Sensitivity in Type-2 Diabetes via miRNA Activation
title_full Methionine Restriction Increases Insulin Sensitivity in Type-2 Diabetes via miRNA Activation
title_fullStr Methionine Restriction Increases Insulin Sensitivity in Type-2 Diabetes via miRNA Activation
title_full_unstemmed Methionine Restriction Increases Insulin Sensitivity in Type-2 Diabetes via miRNA Activation
title_short Methionine Restriction Increases Insulin Sensitivity in Type-2 Diabetes via miRNA Activation
title_sort methionine restriction increases insulin sensitivity in type 2 diabetes via mirna activation
url https://www.shs-conferences.org/articles/shsconf/pdf/2023/23/shsconf_seaa2023_03012.pdf
work_keys_str_mv AT liyuanming methioninerestrictionincreasesinsulinsensitivityintype2diabetesviamirnaactivation
AT yuzifu methioninerestrictionincreasesinsulinsensitivityintype2diabetesviamirnaactivation
AT lituowei methioninerestrictionincreasesinsulinsensitivityintype2diabetesviamirnaactivation
AT lichuanzi methioninerestrictionincreasesinsulinsensitivityintype2diabetesviamirnaactivation